This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03414034
Recruitment Status : Completed
First Posted : January 29, 2018
Last Update Posted : November 1, 2023
Information provided by (Responsible Party):
Cardiff Oncology